Lexaria Bioscience (LEXX) Net Margin Growth (3y) (2020 - 2026)
Lexaria Bioscience (LEXX) Net Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
50,811.00 |
| Date | Value |
|---|
| Feb 28, 2026 |
50,811.00 |
| Aug 31, 2025 |
257,221.00 |
| May 31, 2025 |
457,360.00 |
| Feb 28, 2025 |
-310,007.00 |
| Nov 30, 2024 |
1.58 Mn |
| Aug 31, 2024 |
263,772.00 |
| May 31, 2024 |
339,595.00 |
| Feb 29, 2024 |
62,426.00 |
| Nov 30, 2023 |
102,866.00 |
| Aug 31, 2023 |
502,090.00 |
| May 31, 2023 |
682,622.00 |
| Feb 28, 2023 |
902,283.00 |
| Nov 30, 2022 |
1.06 Mn |
| Aug 31, 2022 |
-15,873.00 |
| May 31, 2022 |
-43,443.00 |
| Feb 28, 2022 |
1.21 Mn |
| Nov 30, 2021 |
-1.12 Mn |
| Aug 31, 2021 |
125,494.00 |
| May 31, 2021 |
118,735.00 |
| Feb 28, 2021 |
59,111.00 |
